Shenzhen Weiguang Biological Products Co., Ltd. primarily engages in the research, development, production, and sale of blood products in China. The company offers human factor VIII, human immunoglobulin (PH4), human rabies immunoglobulin, human tetanus immunoglobulin, human hepatitis B immunoglobulin, human albumin, human histaglobulin, human firbrinogen, human immunoglobulin for intravenous injection freeze-dried, lyophilized human rabies vaccine and human prothrombin complex. Shenzhen Weiguang Biological Products Co., Ltd. was founded in 1985 and is based in Shenzhen, China.
Metrics to compare | 002880 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship002880PeersSector | |
|---|---|---|---|---|
P/E Ratio | 27.8x | 32.5x | −0.6x | |
PEG Ratio | −3.24 | 0.34 | 0.00 | |
Price/Book | 2.7x | 2.4x | 2.6x | |
Price / LTM Sales | 5.6x | 7.2x | 3.3x | |
Upside (Analyst Target) | 17.6% | 13.1% | 41.3% | |
Fair Value Upside | Unlock | −3.3% | 4.9% | Unlock |